The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes

Drug and Alcohol Dependence

Volumn 111, Issue 1-2, 2010, Pages 21-29

  Brunt, Tibor M ^a   van Laar, Margriet ^a   Niesink, Raymond J M ^a   van den Brink, Wim ^b  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adulteration; Amphetamine; Cocaine; Health care outcomes; Hospital admissions; Price; Purity; Time series regression analysis

Indexed keywords

AMPHETAMINE; COCAINE;

ADULT; ARTICLE; DRUG COST; DRUG DEPENDENCE TREATMENT; DRUG MARKETING; DRUG QUALITY; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEIZURE; SUBSTANCE ABUSE; TIME SERIES ANALYSIS;

ADULT; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; COCAINE; COCAINE-RELATED DISORDERS; COMMERCE; FEMALE; HUMANS; MALE; NETHERLANDS; PATIENT ADMISSION; REGRESSION ANALYSIS; STREET DRUGS; TREATMENT OUTCOME;

EID: 77956187506     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.02.023     Document Type: Article

References (44)

1. Behrman A.D. Luck of the draw: common adulterants found in illicit drugs. J. Emerg. Nurs. 2008, 34:80-82.
2. Bertol E., Trignano C., Di Milia M.G., Di P.M., Mari F. Cocaine-related deaths: an enigma still under investigation. Forensic Sci. Int. 2008, 176:121-123.
3. Brownstein H.H., Taylor B.G. Measuring the stability of illicit drug markets: why does it matter?. Drug Alcohol Depend. 2007, 90(Suppl 1):S52-S60.
4. Brunt T.M., Rigter S., Hoek J., Vogels N., van D.P., Niesink R.J. An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 2009, 104:798-805.
5. Callaghan R.C., Cunningham J.K., Victor J.C., Liu L.M. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute-care hospital admissions. Drug Alcohol Depend. 2009, 105:185-193.
6. Caulkins J.P. Drug prices and emergency department mentions for cocaine and heroin. Am. J. Public Health 2001, 91:1446-1448.
7. Caulkins J.P. Price and purity analysis for illicit drug: data and conceptual issues. Drug Alcohol Depend. 2007, 90(Suppl 1):S61-S68.
8. Cole J.C., Goudie A.J., Field M., Loverseed A.C., Charlton S., Sumnall H.R. The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug Alcohol Depend. 2008, 94:183-190.
9. Costa Storti C., De Grauwe P. Globalization and the price decline of illicit drugs. Int. J. Drug Policy 2009, 20:48-61.
10. Darke S., Kaye S., Topp L. Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. Drug Alcohol Depend. 2002, 67:81-88.
11. Dave D. The effects of cocaine and heroin price on drug-related emergency department visits. J. Health Econ. 2006, 25:311-333.
12. Degenhardt L., Roxburgh A., Black E., Bruno R., Campbell G., Kinner S., Fetherston J. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev. 2008, 27:243-252.
13. EMCDDA, 2007. Cocaine and crack cocaine: a growing public health issue. European Monitoring Centre for Drugs and Drug Addiction. Office for Official Publications of the European Communities, Luxembourg. Available at: <> (accessed 21.06.09). http://www.emcdda.europa.eu/attachements.cfm/att_93236_EN_EMCDDA_AR2009_EN.pdf.
14. EMCDDA, 2009. European Monitoring Centre for Drugs and Drug Addiction, Annual Report 2009. Official Publications European Communities. EMCDDA Annual Report, Available at: <> (accessed 01.12.09). http://www.emcdda.europa.eu/attachements.cfm/att_93236_EN_EMCDDA_AR2009_EN.pdf.
15. Gelper S., Croux C. Multivariate out-of-sample tests for Granger causality. Comput. Stat. Data Anal. 2006, 51:3319-3329.
16. Glauser J., Queen J.R. An overview of non-cardiac cocaine toxicity. J. Emerg. Med. 2007, 32:181-186.
17. Goudie A.J., Sumnall H.R., Field M., Clayton H., Cole J.C. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases. Drug Alcohol Depend. 2007, 89:107-115.
18. Hyatt R.R., Rhodes W. The price and purity of cocaine: the relationship to emergency room visits and death, and to drug use among arrestees. Stat. Med. 1995, 14:655-668.
19. Johansen S. Likelihood-based Inference in Cointegrated Vector Autoregressive Models 1996, Oxford University Press, Oxford, United Kingdom. 1st ed.
20. Knuepfer M.M. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol. Ther. 2003, 97:181-222.
21. Ladroue C., Guo S., Kendrick K., Feng J. Beyond element-wise interactions: identifying complex interactions in biological processes. PLoS One 2009, 4:e6899.
22. Lange R.A., Hillis L.D. Cardiovascular complications of cocaine use. New Engl. J. Med. 2001, 345:351-358.
23. Leikin J.B., Morris R.W., Warren M., Erickson T. Trends in a decade of drug abuse presentation to an inner city ED. Am. J. Emerg. Med. 2001, 19:37-39.
24. Lütkepohl H. New Introduction to Multiple Time Series Analysis 2006, Springer-Verlag, New York, United States. 1st ed.
25. McCance-Katz E.F., Kosten T.R., Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone-a multiple-dose study. Biol. Psychiatry 1998, 44:250-259.
26. McCann U.D., Ricaurte G.A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci. Biobehav. Rev. 2004, 27:821-826.
27. Pai S.A., Lakshmi P.K., Rao B.C., Sahni P. Pharmaceutical companies and the third world. Lancet 2003, 361:1136-1137.
28. Pennings E.J., Leccese A.P., Wolff F.A. Effects of concurrent use of alcohol and cocaine. Addiction 2002, 97:773-783.
29. Peterson B.S., Potenza M.N., Wang Z., Zhu H., Martin A., Marsh R., Plessen K.J., Yu S. An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am. J. Psychiatry 2009, 166:1286-1294.
30. Ramsey J.D., Butcher M.A., Murphy M.F., Lee T., Johnston A., Holt D.W. A new method to monitor drugs at dance venues. BMJ 2001, 323:603.
31. Rodenburg G, Spijkerman R, van den Eijnden R, van de Mheen D. National prevalence research substance abuse 2005. 2007. IVO, Rotterdam. Available at: <> (accessed 07.05.09). http://www.hetccv.nl/binaries/ccv/dossiers/bestuurlijkhandhaven/drugsbeleid/cannabis/nationaal_onderzoek_middelengebruik.pdf.
32. Schifano F., Corkery J. Cocaine/crack cocaine consumption, addiction treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990-2004). J. Psychopharmacol. 2008, 22:71-79.
33. Shearer J., Gowing L.R. Pharmacotherapies for problematic psychostimulant use: a review of current research. Drug Alcohol Rev. 2004, 23:203-211.
34. Smithson M., McFadden M., Mwesigye S.E., Casey T. The impact of illicit drug supply reduction on health and social outcomes: the heroin shortage in the Australian Capital Territory. Addiction 2004, 99:340-348.
35. Spruit I.P. Monitoring synthetic drug markets, trends, and public health. Subst. Use Misuse 2001, 36:23-47.
36. Sumnall H.R., Tyler E., Wagstaff G.F., Cole J.C. A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers. Drug Alcohol Depend. 2004, 76:93-99.
37. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2008. Vienna, United Nations. Available at: <> (accessed 10.09.09). http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf.
38. Van Laar M.W, Cruts A.A.N, Verdurmen J.E.E, van Ooyen-Houben M.M.J, Meijer R.F The Netherlands National Drug Monitor: Annual Report 2007 2008, Trimbos Institute, Utrecht.
39. Vitale S., van de Mheen D. Illicit drug use and injuries: a review of emergency room studies. Drug Alcohol Depend. 2006, 82:1-9.
40. Vogels N., Brunt T.M., Rigter S., Van Dijk P., Vervaeke H., Niesink R.J.M. Content of ecstasy in the Netherlands: 1993-2008. Addiction 2009, 104:2057-2066.
41. Weatherburn D., Jones C., Freeman K., Makkai T. Supply control and harm reduction: lessons from the Australian heroin 'drought'. Addiction 2003, 98:83-91.
42. Weber J.E., Chudnofsky C.R., Boczar M., Boyer E.W., Wilkerson M.D., Hollander J.E. Cocaine-associated chest pain: how common is myocardial infarction?. Acad Emerg. Med. 2000, 7:873-877.
43. Westover A.N., McBride S., Haley R.W. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch. Gen. Psychiatry 2007, 64:495-502.
44. Williams J., Pacula R.L., Chaloupka F.J., Wechsler H. College students' use of cocaine. Subst. Use Misuse 2006, 41:489-509.